The California-based company did not immediately respond to a Washington Post request for comment late Friday, but company spokesman Chris Ridley told Bloomberg News the recall involved some 55,000 vials of the drug, enough to treat 11,000 hospitalized patients.
Veklury antiviral coronavirus treatment vials recalled by Gilead Sciences – The Washington Post
